Ozempic and Wegovy may raise hair loss risk in some men
Researchers found the association persisted after accounting for hypertension and other factors, suggesting a shared genetic pathway may help explain hair loss in some users.
6 Articles
6 Articles
Science Daily
MSNBCTV NEWSOzempic and Wegovy may raise hair loss risk in some men
GLP-1 drugs such as Ozempic, Wegovy, and Zepbound may increase hair-loss risk by 7% in men who are already genetically susceptible to male-pattern baldness. The findings suggest thinning hair may not be caused only by rapid weight loss and could also reflect a biological link between GLP-1 activity and hair follicles.
A new study suggests that GLP-1 drugs such as Ozempic, Vegovy, and Zepbound, used for weight loss, may increase the risk of hair loss in men. Researchers have found that this risk is particularly high in those who are already genetically predisposed to the common male pattern hair loss problem.
Ozempic, Wegovy, and Zepbound increase hair loss risk. A new study has revealed a potential risk of hair loss with Ozempic, Wegovy, and Zepbound, medications used for weight loss and type 2 diabetes. According to researchers at NYU Langone Health, men genetically predisposed to male-pattern baldness may have a 7 percent increased risk. Until now, rapid weight loss was considered the primary cause of hair loss, but the study also points to the po…
The most popular drugs for weight loss and diabetes control are related to an increased risk of hair loss. Several recent studies confirm what many users have already noticed in networks.
Coverage Details
Bias Distribution
- 100% of the sources are Center
Factuality
To view factuality data please Upgrade to Premium
